rs146806202

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_182925.5(FLT4):​c.3908G>C​(p.Gly1303Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00302 in 1,613,944 control chromosomes in the GnomAD database, including 22 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0026 ( 1 hom., cov: 33)
Exomes 𝑓: 0.0031 ( 21 hom. )

Consequence

FLT4
NM_182925.5 missense

Scores

1
16

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 1.35

Publications

9 publications found
Variant links:
Genes affected
FLT4 (HGNC:3767): (fms related receptor tyrosine kinase 4) This gene encodes a tyrosine kinase receptor for vascular endothelial growth factors C and D. The protein is thought to be involved in lymphangiogenesis and maintenance of the lymphatic endothelium. Mutations in this gene cause hereditary lymphedema type IA. [provided by RefSeq, Jul 2008]
FLT4 Gene-Disease associations (from GenCC):
  • lymphatic malformation 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
  • capillary infantile hemangioma
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • congenital heart defects, multiple types, 7
    Inheritance: AD Classification: STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • lymphatic malformation
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • tetralogy of fallot
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0036003888).
BP6
Variant 5-180603376-C-G is Benign according to our data. Variant chr5-180603376-C-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 263053.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00259 (394/152354) while in subpopulation SAS AF = 0.0089 (43/4834). AF 95% confidence interval is 0.00679. There are 1 homozygotes in GnomAd4. There are 204 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 394 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FLT4NM_182925.5 linkc.3908G>C p.Gly1303Ala missense_variant Exon 30 of 30 ENST00000261937.11 NP_891555.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FLT4ENST00000261937.11 linkc.3908G>C p.Gly1303Ala missense_variant Exon 30 of 30 1 NM_182925.5 ENSP00000261937.6
FLT4ENST00000502603.5 linkn.608G>C non_coding_transcript_exon_variant Exon 4 of 4 2

Frequencies

GnomAD3 genomes
AF:
0.00257
AC:
392
AN:
152236
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000531
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00523
Gnomad ASJ
AF:
0.000864
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00847
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.00340
Gnomad OTH
AF:
0.00525
GnomAD2 exomes
AF:
0.00323
AC:
801
AN:
247888
AF XY:
0.00364
show subpopulations
Gnomad AFR exome
AF:
0.000373
Gnomad AMR exome
AF:
0.00232
Gnomad ASJ exome
AF:
0.000498
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000468
Gnomad NFE exome
AF:
0.00343
Gnomad OTH exome
AF:
0.00361
GnomAD4 exome
AF:
0.00306
AC:
4473
AN:
1461590
Hom.:
21
Cov.:
32
AF XY:
0.00330
AC XY:
2400
AN XY:
727066
show subpopulations
African (AFR)
AF:
0.000836
AC:
28
AN:
33478
American (AMR)
AF:
0.00248
AC:
111
AN:
44670
Ashkenazi Jewish (ASJ)
AF:
0.000498
AC:
13
AN:
26118
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39698
South Asian (SAS)
AF:
0.0101
AC:
872
AN:
86186
European-Finnish (FIN)
AF:
0.000150
AC:
8
AN:
53402
Middle Eastern (MID)
AF:
0.0141
AC:
81
AN:
5756
European-Non Finnish (NFE)
AF:
0.00283
AC:
3144
AN:
1111894
Other (OTH)
AF:
0.00358
AC:
216
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
253
505
758
1010
1263
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
122
244
366
488
610
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00259
AC:
394
AN:
152354
Hom.:
1
Cov.:
33
AF XY:
0.00274
AC XY:
204
AN XY:
74490
show subpopulations
African (AFR)
AF:
0.000529
AC:
22
AN:
41584
American (AMR)
AF:
0.00523
AC:
80
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.000864
AC:
3
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.00890
AC:
43
AN:
4834
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.0136
AC:
4
AN:
294
European-Non Finnish (NFE)
AF:
0.00340
AC:
231
AN:
68030
Other (OTH)
AF:
0.00520
AC:
11
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
22
44
65
87
109
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00249
Hom.:
0
Bravo
AF:
0.00280
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.00349
AC:
30
ExAC
AF:
0.00334
AC:
405
Asia WGS
AF:
0.00289
AC:
10
AN:
3478
EpiCase
AF:
0.00349
EpiControl
AF:
0.00416

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Dec 08, 2020
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Nov 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

FLT4: BP4, BS1, BS2

Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

not specified Benign:1
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.075
BayesDel_addAF
Benign
-0.50
T
BayesDel_noAF
Benign
-0.48
CADD
Benign
15
DANN
Benign
0.86
DEOGEN2
Benign
0.13
T
Eigen
Benign
-1.5
Eigen_PC
Benign
-1.4
FATHMM_MKL
Benign
0.28
N
LIST_S2
Benign
0.75
T
MetaRNN
Benign
0.0036
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Uncertain
2.2
M
PhyloP100
1.3
PrimateAI
Benign
0.31
T
PROVEAN
Benign
-1.1
N
REVEL
Benign
0.17
Sift
Benign
0.46
T
Sift4G
Benign
0.54
T
Vest4
0.14
ClinPred
0.0033
T
GERP RS
0.47
Varity_R
0.049
gMVP
0.11
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs146806202; hg19: chr5-180030376; COSMIC: COSV56118431; COSMIC: COSV56118431; API